Stellanin ointment tube 20g 3%

Description

Composition
Active substance:
100 g of ointment contains: 1,3-diethylbenzimidazole triiodide – 3.0 g
Excipients:
Povidone (polyvinylpyrrolidone, low molecular weight), dimexide, glycerol (glycerin), vaseline.
Description:
The ointment is dark brown in color with a faint characteristic odor.
Product form:
Ointment for external application of 3%. 20 g aluminum tubes, together with instructions for use in cardboard packs.
Contraindications
Hypersensitivity to the drug, hyperthyroidism, thyroid adenoma, renal failure, simultaneous treatment with radioactive iodine, children under the age of 18, I trimester of pregnancy.
Carefully:
Chronic renal failure, II and III trimester of pregnancy, lactation.
Dosage
3%
Indications
Trophic ulcers of the lower extremities; bed sores; burns of degree I and II; abrasions, cuts, scratches, cracks, scratches, including insect bites; additional treatment aseptic surgical wounds (after excision, coagulation, episiotomy, for the treatment of fractures of the skin, wounds and sutures); acceleration of healing of the skin graft.
Interaction with other drugs
It should not be administered in conjunction with other antiseptic agents containing mercury, oxidants, alkalis, and cationic surfactants. The presence of blood bactericidal action of the preparation can be reduced.
Overdose
Overdose cases are not described. If you accidentally taking the drug inside may cause nausea and vomiting. It is necessary to wash out the stomach and seek medical advice, symptomatic treatment if necessary.
pharmachologic effect
Pharmacological group:
Tissue regeneration stimulator.
Pharmacodynamics:
The active component of the drug is 1.3 Stellanin® diethylbenzimidazole triiodide. The mechanism of the pharmacological activity of the preparation is the direct action of the recovery of 1,3-diethylbenzimidazole on damaged skin. Active iodine, part of the drug to inactivate bacterial wall proteins and enzymatic proteins of the bacteria, thereby providing a bactericidal effect. Stellanin protects the surface of the wound from infection, inhibits for infection and promotes healing.
Pharmacokinetics:
Systemic absorption of the active substance is not damaged even when skin, nevertheless, present in the wound therapeutic concentrations of the drug.
Conditions of supply of pharmacies
Without recipe.
side effects
In rare cases, possible allergic skin reactions (pruritus, redness of the skin) and when they appear should stop using the product.
special instructions
Ointment can not be applied to mucous membranes. If the product enters the eyes or the mucous membrane must be washed with warm water.
Features of the application of the drug Stellanin®
In phase II of wound healing process (regeneration phase, formation and maturation of the granulation tissue) application of ointments with high osmotic activity can lead to unwanted effects due to overdrying young regenerating skin.
Preparation “Stellanin® ointment for topical application of 3%” low osmotic potential provides optimal conditions for the growth of granulation while suppressing remaining of microorganisms and prevention of reinfection of the wound.
Contained in petrolatum ointment covers the regenerating wound protective layer, glycerin moisturizes and softens the skin formed and the active components of the ointment – 1,3-diethylbenzimidazole triiodide it prevents secondary infection and accelerates regeneration.
As used in the formulation “Stellanin® ointment for topical application of 3%” as the substance of 1,3-diethylbenzimidazole triiodide provides antimicrobial, anti-inflammatory and regenerative action necessary for speedy and successful wound healing.
Storage conditions
In a dry, dark place at a temperature of 0-25 ° C. Keep out of the reach of children.
Dosing and Administration
Outwardly.
The preparation is applied on the damaged skin surface so that the skin was covered with the drug completely. The duration and frequency of application of the drug depends on the severity of the disease and the localization process. The daily dose should not exceed ’10 Perhaps the use of occlusive dressings and patches.
When granulating treatment of burns, wounds and trophic ulcers with slight exudation formulation is applied uniformly to a thickness of 1.0-1.5 mm so that the entire surface was covered struck ointment, and impose a sterile gauze bandage. Change of dressings is performed 1 time per day 1-2 in the treatment of burns and of 1-2 times a day in the treatment of wounds and trophic ulcers. When drug treatment open burns method applied 1-2 times per day. The duration of treatment is determined by the dynamics of epithelialization of wounds.
With minor skin injuries (abrasions, cuts, scratches, cracks, scratches) formulation applied thinly to the skin surface 2 times per day.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist